Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-04-09

EMA Authorised: Sibnayal (potassium citrate monohydrated;potassium hydrogen carbonate) — Advicenne S.A.

View source ↗

Summary

The EMA authorised Sibnayal (potassium citrate monohydrated and potassium hydrogen carbonate) for renal tubular acidosis–related acidosis. The marketing authori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sibnayal (potassium citrate monohydrated; potassium hydrogen carbonate)

Snippet

Status: Authorised. Therapeutic area: Acidosis, Renal Tubular. MAH: Advicenne S.A.. Decision date: 09/04/2026